"On behalf of the Endocrine Society, the world’s largest professional organization of endocrinologists, we are pleased to endorse the Diabetes Prevention Program Reauthorization Act of 2024. Thank you for introducing this important legislation. Founded in 1916, the Endocrine Society represents approximately 18,000 physicians and scientists engaged in the treatment and research of endocrine disorders such as diabetes, hypertension, infertility, obesity, osteoporosis, endocrine tumors cancers (i.e., thyroid, adrenal, ovarian, pituitary), and thyroid disease. Our membership includes over 11,000 clinicians who are on the front lines in treating diabetes and obesity, two of the most common chronic illnesses in the United States."
Read the Full Letter